Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#ED1C24
Crimson
237, 28, 36
358, 85, 52
0, 88, 85, 7
The company has successfully derived mRNA vaccine candidates using its patented nucleotide technology, which does not infringe on existing mRNA COVID-19 vaccine patents. With a mission to be the First Mover in the mRNA drug development market, mCureX aims to rapidly develop mRNA vaccines and therapies using its exclusive mRNA molecular platform technology. The company plans to expand its pipeline to include various indications such as infectious diseases like COVID-19 and influenza, as well as cancer, respiratory diseases, and liver diseases.
Expect mCureX to mark a new chapter in the field of mRNA therapeutics
Company type
Privately Held
Year founded
2021
Company size
11-50 employees
The mCureX Therapeutics name, logos and brand assets are trademarks of mCureX Therapeutics and its affiliates. Brandfetch isn't affiliated with or endorsed by mCureX Therapeutics. Their use is subject to mCureX Therapeutics's brand guidelines.
